Frog legs are a well known delicacy of both French and Cantonese cuisine.
Frog legs are a well known delicacy of both French and Cantonese cuisine. However, the farming of frog legs is not tightly controlled and residues of veterinary drugs above the acceptable level have been found in imports. A team of scientists from the USA has therefore developed a liquid chromatography quadrupole time‑of‑flight (Q-TOF) mass spectrometry method to analyse the drug residues found in frog legs.1
First, several veterinary drugs were selected as target compounds to validate the method, including trimethoprim, sulfamethoxazole, chloramphenicol, quinolones and FQs. Tissue was extracted from the store-bought samples with dilute acetic acid and acetonitrile with added sodium chloride and then centrifuged. The extracts were then evaporated and reconstituted in mobile phase. The team evaluated the data collected by comparing the accurate mass and retention times of compounds to a database containing information for veterinary drugs. They found that the target compounds were consistently at higher than acceptable levels and they were able to estimate the amount of residue present. This method was then used to analyse imported frog legs and many of the residues were found in the samples, often in combination and at high concentrations (> 10 ng/g).
The team concluded that this was a good method that provided excellent sensitivity when compared with alternative MS procedures.
1. Justin R. Carr et al., Journal of Agricultural and Food Chemistry, 60(18), 4430–4439 (2012).
This story originally appeared in The Column. Click here to view that issue.
A Dream Come True: Separation Science at Analytica
November 6th 2024At Analytica this year, an oral session titled “A Dream Comes True: Fantastic News from Analytical Chemistry” focused on cutting-edge techniques in separation science in Hall 5 of the International Congress Center Munich (ICM) International Congress Center Munich (ICM).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.